Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2011-03-01 (15 years)Status: ActiveBusiness sector: Commerce de gros (commerce interentreprises) de produits pharmaceutiquesLocation: VILLENNES-SUR-SEINE (78670), Yvelines
SARL MAG2HEALTH : revenue, balance sheet and financial ratios
SARL MAG2HEALTH is a French company
founded 15 years ago,
specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques.
Based in VILLENNES-SUR-SEINE (78670),
this company of category PME
shows in 2021 a revenue of 3.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SARL MAG2HEALTH (SIREN 530485010)
Indicator
2024
2023
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
3 429 696 €
2 391 902 €
2 191 482 €
2 743 861 €
2 305 557 €
1 960 948 €
Net income
50 535 €
186 665 €
315 247 €
196 594 €
69 920 €
143 744 €
124 514 €
35 123 €
EBITDA
N/C
N/C
450 271 €
277 632 €
149 794 €
226 484 €
179 701 €
44 176 €
Net margin
N/C
N/C
9.2%
8.2%
3.2%
5.2%
5.4%
1.8%
Revenue and income statement
In 2024, SARL MAG2HEALTH generates positive net income of 51 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 35 k€ -> 51 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
50 535 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 13%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 38%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
12.935%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
37.603%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Debt ratio
5.435
2.225
0.613
0.0
0.0
0.0
0.0
12.935
Financial autonomy
27.784
45.695
53.018
47.94
44.666
49.374
51.91
37.603
Repayment capacity
0.525
0.059
0.018
0.0
0.0
0.0
None
None
Cash flow / Revenue
1.222%
5.688%
5.829%
4.849%
8.265%
9.128%
None%
None%
Sector positioning
Debt ratio
12.942024
2021
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Average+30 pts over 3 years
In 2024, the debt ratio of SARL MAG2HEALTH (12.94) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
37.6%2024
2021
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Average-16 pts over 3 years
In 2024, the financial autonomy of SARL MAG2HEALTH (37.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
0.0 years2021
2021
Q1: 0.0 years
Med: 0.01 years
Q3: 1.79 years
Excellent
In 2021, the repayment capacity of SARL MAG2HEALTH (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 155.39. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
155.387
Liquidity indicators evolution SARL MAG2HEALTH
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Liquidity ratio
125.026
168.121
192.16
174.263
172.044
185.762
194.109
155.387
Interest coverage
36.527
4.08
9.805
9.942
2.482
4.891
None
None
Sector positioning
Liquidity ratio
155.392024
2021
2023
2024
Q1: 132.74
Med: 202.27
Q3: 325.9
Average-10 pts over 3 years
In 2024, the liquidity ratio of SARL MAG2HEALTH (155.39) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
4.89x2021
2021
Q1: 0.0x
Med: 0.39x
Q3: 4.57x
Excellent
In 2021, the interest coverage of SARL MAG2HEALTH (4.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SARL MAG2HEALTH
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Operating WCR
309 438 €
100 868 €
256 085 €
365 890 €
148 418 €
159 549 €
0 €
0 €
Inventory turnover (days)
21
25
15
17
17
14
0
0
Customer payment term (days)
56
14
33
54
35
23
0
0
Supplier payment term (days)
89
44
45
49
58
43
0
0
Positioning of SARL MAG2HEALTH in its sector
Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques
Valuation estimate
Based on 124 transactions of similar company sales
(all years),
the value of SARL MAG2HEALTH is estimated at
41 515 €
(range 15 801€ - 151 608€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
124 transactions
15k€41k€151k€
41 515 €Range: 15 801€ - 151 608€
NAF 5 all-time
Valuation method used
Net Income Multiple
50 535 €
×
0.8x
=41 515 €
Range: 15 801€ - 151 609€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)
Compare SARL MAG2HEALTH with other companies in the same sector:
Yes, SARL MAG2HEALTH generated a net profit of 51 k€ in 2024.
Where is the headquarters of SARL MAG2HEALTH ?
The headquarters of SARL MAG2HEALTH is located in VILLENNES-SUR-SEINE (78670), in the department Yvelines.
Where to find the tax return of SARL MAG2HEALTH ?
The tax return of SARL MAG2HEALTH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SARL MAG2HEALTH operate?
SARL MAG2HEALTH operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart